Newsroom
We are more than a pump company. We expertly support people living with diabetes and enable providers through an integrated platform that brings together medicine, analytics, support, and smart technology.
Tandem Diabetes Care takes an innovative, user-centric approach to the design, development, and commercialization of products for people living with diabetes who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology or Basal-IQ technology. Tandem Diabetes Care is based in San Diego, California.
Recent Press Releases
Get the latest information about Tandem Diabetes Care.
- 04-2024 Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
- 03-2024 Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
- 03-2024 Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
- 02-2024 Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance
- 02-2024 Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System
Media Assets
Please comply with our brand guidelines. All logos are trademarks of Tandem Diabetes Care, Inc. and unauthorized use of logos, images, or videos is prohibited.